Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-122

Hi Sentisure,

And thanks for your reply.

I too am a long term holder, although given the release of the current latest information to see where the SP is now, begs for more answers as to what management intent to do, or if there is something closer in the pipelines to assist the SP to remain at appreciative price given the progress.

Yes it happens in alot of other stocks, and yes it is highly frustrating. Although as others have mentioned, there should be more to this recent report.

obviously day traders play a significant part, but still, on such a good reading, we are worse of than before the reading going of the current SP.

Fingers crossed there are alot of behind the door talks in progress.